Stem Cell Therapeutics's Profile
Welcome To The Stem Cell Therapeutics HUB On AGORACOM Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.
About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a public biotechnology company (TSX VENTURE:SSS) focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is a leader in the development of therapies that utilize drugs to stimulate a patient's own resident stem cells. The Company's programs aim to repair brain and nerve function lost due to disease or injury. The Company's extensive patent portfolio of owned and licensed intellectual property supports the potential expansion into future clinical programs in numerous neurological diseases such as traumatic brain injury, multiple sclerosis, Huntington's disease, Alzheimer's disease, and ALS.
Last changed at 10-Sep-2010 12:10AM by Moneytospend
Management & Directors
Broker Fact Sheet
-
SSS Broker Fact Sheet
Thu Mar 29, 2019Fact sheet details
Company Links
Stem Cell Therapeutics
Symbol
SSS
Exchange
TSX-V
Shares
153,005,004 as of April 13/10
Industry
Technology & Medical
Website